Aaron Schacht
CEOBiomEditAndrea Iucci
CEONorbrook Laboratories Ltd.Linda Rhodes
VMD, PhD, Independent and ex-CSOIndependent Animal HealthDr. Rhodes has over 30 years of accomplishments in human and animal drug discovery, development, biomedical research, and clinical veterinary medicine.
Dr. Rhodes was educated at the University of Pennsylvania School of Veterinary Medicine (VMD) and Cornell University (PhD). She has an extensive background in physiology, veterinary medicine, and drug development, and many publications in peer-reviewed journals. Dr. Rhodes practiced clinical veterinary medicine for five years, with experience in both companion and farm animal practice. As a senior research fellow at Merck Research Laboratories for 8 years, she led pre-clinical biology evaluation of several marketed human drugs. She worked for Merial Ltd. as director of large animal development projects, leading project teams developing novel compounds for a variety of indications. In April 2001, she formed AlcheraBio, a consulting, marketing, and contract research firm specializing in developing new drugs for animals, working with biotechnology and animal health companies world-wide. AlcheraBio was acquired in 2008 by Argenta, and Dr. Rhodes served as executive vice president to transition the company when in 2011, she accepted a position as CEO of Aratana Therapeutics, a startup company developing innovative new medicines for dogs and cats. Subsequently, when the company became public she served as its Chief Scientific Officer. During her 5-year tenure, the company achieved FDA approval of three new pet therapeutics: Galliprant, Nocita and Entyce. She is currently retired and an independent consultant. She is a member of the Board of Directors of Zoetis, and serves on the Scientific Advisory Boards of the Alliance for Contraception in Dogs and Cats and the Michelson Found Animals Foundation. She founded Feather in Her Cap, a non-profit that recognizes the achievement of women in the animal health industry. She is the recipient of the Iron Paw Award.
Cynthia Cole
Technical PartnerDigitalis VenturesJesper Nordengaard
CEODechraJulia Stephanus
PartnerBorealis VenturesJulia has been a visionary entrepreneur and strategic brand builder in the veterinary industry for 30+ years. Her achievements include building and scaling two successful start-up veterinary pharmaceutical businesses and launching 28 veterinary products. She was Founder and CEO of Summit VetPharm, which exited to Ceva Animal Health in 2010. As Chief Commercial Officer of Aratana Therapeutics (PETX), she was instrumental in the IPO and the buildout of a fully integrated commercial organization. Julia led the co-promotion and the licensing of Aratana’s lead osteoarthritis product, Galliprant®, to Elanco. Aratana exited to Elanco in 2019.
Julia is Founder and President of Avviare, LLC, providing consulting services to start-ups and established players in veterinary biopharmaceuticals. In addition to the start-up experience, Julia’s career includes senior-level positions at Ceva, Forest Laboratories (Allergan) and Pfizer Animal Health (Zoetis) and their legacy companies.
Julia presently serves on the Boards of PBI Gordon, ReduxBio, and Jenga Biosciences. Julia is a Founding Director and Board Member of Feather in Her Cap, recognizing outstanding women in Animal Health.
Julia received her Bachelor of Arts from Indiana University in Bloomington, Indiana, with additional education at the Wharton School of Business, Columbia University, the University of Chicago, and Harvard University.
Dr. Cherice Roth
Chief Veterinary Officer, Digital Pet HealthMars Veterinary HealthBrett Wong
PrincipalAnterra CapitalDain Clare
Vice PresidentNovaQuest Capital ManagementAndrew McKenzie
CEOPrecision Livestock TechnologiesJason Scott
Founder & Managing Partner525 VenturesNeal Fishman
CTO of Data-Based PathologyIBMGeoffrey Shmigelsky
CTOOneCupAIGarth Jordan
CEOAmerican Animal Hospital AssociationKristin Wuhrman
Board of DirectorsCATalyst CouncilGerardo Bluske
CEO & Co-FounderByBugGerardo is an Industrial Engineer with a master’s degree in Business Management. After eight years of experience in various multinational companies, he leveraged his expertise to create a high-impact venture revolutionizing feed and biotherapeutics manufacturing.
ByBug empowers companies to enhance animal health through customized feed solutions. The company has developed an innovative biomanufacturing platform that utilizes the Black Soldier Fly (BSF) as a natural bioreactor to produce recombinant proteins—such as immunostimulants, peptides, and antibodies—directly within insect meal.
ByBug specializes in engineering these strains and licensing the technology to insect breeders. The breeders use the strains to produce enriched insect meal, which is incorporated into animal feed as a nutritional and health-enhancing additive, delivering value throughout the supply chain.
Ashley Pochick
VP Supplier RelationsInventory AllyDr Christie Long
Chief Medical OfficerModern AnimalDr Eve Hanks
Chief Executive Officer & FounderMI:RNA DiagnosticsLukasz Bzdzion
Founder & CEOBioceltixJeffrey Emmons
VP Venture and GrowthEmil Capital PartnersMeaghan Gilhooly
VP Veterinary AffairsBanfield Pet HospitalsLinda Block
InvestorImpactology PartnersMathieu Glassman
Founder & CEODr CuddlesValerie Bertle
General PartnerYellow Rocks CapitalDace Graham
Founder Managing Partner1731MGMTCharles Tapp
Founder & General PartnerVetted CapitalSam Razor
Executive ChairmanParasight SystemsArjun Ganesan
CEOAnceraDr Lenore Bacek, DVM
VP Clinical AffairsBlue Pearl Specialty & Emergency Pet HospitalAngelo Gatto
CEOChanelle PharmaCaroline Heller
Chief Business OfficerRumin8Carlos Saviani
Beef Sustainability DirectorCargillBruce Truman
President and FounderBLT Technology & Innovation GroupHui Cai
Senior Vice President, Head of Clinical ManufacturingWuXi BiologicsSteve Shell
PresidentMWI Animal HealthCeline Halioua
Founder & CEOLoyalJules Benson
PrincipalTapetum Lucidum ConsultingCindy Trice
Chief Veterinary OfficerhoundScott Maloney
Senior Partner & FounderCrain ConsultingManoj Babu
VP Business DevelopmentSyngene InternationalPatricia Porter
CEOVEA - Veternarian Exam AssistantNatalie Marks
Executive CommitteeVANEDr. Natalie Marks is a small animal veterinarian with over twenty years of clinical experience. She owned the largest animal hospital in Chicago. More recently, she has been the founder and president of MarksDVMConsulting, an educational and strategy consulting firm working with companies of all stages nationally and internationally. She is also on the Executive Committee of VANE, the premier veterinary angel network investor group. VANE currently has 28 portfolio companies and provides direction, connection, and funding to start-ups in the animal health space.
Douglas Aspros
Chief Veterinary OfficerVeterinary Practice PartnersDerrick Kraemer
CEODoppler Veterinary NetworkWilliam Tancredi
Chief of StaffOld Ridge Veterinary HospitalCandise Goodwin
FounderOutlier AdvisorsKeith True
FounderTrue.Vet and True Vet PotentialNeshmeen Faatimah
CEO & C-FounderNuzzle Technologies, IncSteve Kirton
Angel InvestorVANEDavid Haworth
EVP, R&DEmbarkRon Phillips
Senior Vice President, PolicyAnimal Health InstituteBrian Earnest
Lead Protein Industry AnalystCoBankDavid Kincaid
OwnerDedekind Cut LabsAlex Cohen
Chief Technology OfficerABC IntelligenceLily Chen
Owner / VeterinarianIntegrative Pet Wellness CenterTyre Grant
VP Global Product DevelopmentElancoSebastian Gabor
Founder and CEODigitailJames King
Vice President of Software Engineering, Patterson VeterinaryAnimal Care TechnologiesLisa Lee
SVP, Petcare, Corporate & IndependentZoetisRichard Goldstein
SVP, Global Chief Medical OfficerZoetisKathleen Crispi
Director of InnovationTrouw NutritionAdam Little
Chief Medical OfficerGoFetch.caIssiah Owens
Director of Animal Health ProductsDAW Systems